PL117242B1 - Method for manufacturing synthetic aluminium and magnesium silicatejuminija - Google Patents
Method for manufacturing synthetic aluminium and magnesium silicatejuminija Download PDFInfo
- Publication number
- PL117242B1 PL117242B1 PL1979218133A PL21813379A PL117242B1 PL 117242 B1 PL117242 B1 PL 117242B1 PL 1979218133 A PL1979218133 A PL 1979218133A PL 21813379 A PL21813379 A PL 21813379A PL 117242 B1 PL117242 B1 PL 117242B1
- Authority
- PL
- Poland
- Prior art keywords
- aqueous solution
- magnesium
- added
- solution containing
- product
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 24
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title description 10
- 239000011777 magnesium Substances 0.000 title description 10
- 229910052749 magnesium Inorganic materials 0.000 title description 10
- 229910052782 aluminium Inorganic materials 0.000 title description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 title 1
- 239000004411 aluminium Substances 0.000 title 1
- 239000000047 product Substances 0.000 claims description 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- 239000007864 aqueous solution Substances 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 13
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 12
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 claims description 12
- 239000002244 precipitate Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 9
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 7
- 239000001110 calcium chloride Substances 0.000 claims description 7
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 7
- 229910001424 calcium ion Inorganic materials 0.000 claims description 7
- -1 polydimethylsiloxane Polymers 0.000 claims description 7
- 239000004115 Sodium Silicate Substances 0.000 claims description 6
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 claims description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 6
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims description 6
- 229910052911 sodium silicate Inorganic materials 0.000 claims description 6
- 229910052681 coesite Inorganic materials 0.000 claims description 5
- 229910052906 cristobalite Inorganic materials 0.000 claims description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 5
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 claims description 5
- 229910052682 stishovite Inorganic materials 0.000 claims description 5
- 229910052905 tridymite Inorganic materials 0.000 claims description 5
- KKCBUQHMOMHUOY-UHFFFAOYSA-N Na2O Inorganic materials [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 235000012239 silicon dioxide Nutrition 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 235000019738 Limestone Nutrition 0.000 claims 2
- 239000006028 limestone Substances 0.000 claims 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims 1
- 229910052593 corundum Inorganic materials 0.000 claims 1
- BUACSMWVFUNQET-UHFFFAOYSA-H dialuminum;trisulfate;hydrate Chemical compound O.[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O BUACSMWVFUNQET-UHFFFAOYSA-H 0.000 claims 1
- 229910001845 yogo sapphire Inorganic materials 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 10
- 230000002496 gastric effect Effects 0.000 description 10
- 208000025865 Ulcer Diseases 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 231100000397 ulcer Toxicity 0.000 description 9
- 239000000499 gel Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 201000006549 dyspepsia Diseases 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 208000007882 Gastritis Diseases 0.000 description 4
- 206010030216 Oesophagitis Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 230000001458 anti-acid effect Effects 0.000 description 4
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 208000006881 esophagitis Diseases 0.000 description 4
- 208000024798 heartburn Diseases 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000003472 neutralizing effect Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 230000003139 buffering effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000012895 Gastric disease Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000013065 commercial product Substances 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 208000018556 stomach disease Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010012713 Diaphragmatic hernia Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 150000001621 bismuth Chemical class 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 230000007665 chronic toxicity Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 201000005890 congenital diaphragmatic hernia Diseases 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 229960001275 dimeticone Drugs 0.000 description 1
- KZHJGOXRZJKJNY-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Si]=O.O=[Al]O[Al]=O.O=[Al]O[Al]=O.O=[Al]O[Al]=O KZHJGOXRZJKJNY-UHFFFAOYSA-N 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006069 physical mixture Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/20—Silicates
- C01B33/26—Aluminium-containing silicates, i.e. silico-aluminates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH938478 | 1978-09-07 | ||
CH589079A CH639630A5 (en) | 1979-06-22 | 1979-06-22 | Synthetic magnesium aluminium silicate, process for its manufacture and pharmaceutical compositions comprising it |
Publications (2)
Publication Number | Publication Date |
---|---|
PL218133A1 PL218133A1 (de) | 1980-06-02 |
PL117242B1 true PL117242B1 (en) | 1981-07-31 |
Family
ID=25698589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL1979218133A PL117242B1 (en) | 1978-09-07 | 1979-09-05 | Method for manufacturing synthetic aluminium and magnesium silicatejuminija |
Country Status (13)
Country | Link |
---|---|
US (1) | US4339421A (de) |
AR (1) | AR221103A1 (de) |
DD (1) | DD145740A5 (de) |
DE (1) | DE2936078C2 (de) |
ES (1) | ES484103A1 (de) |
FR (1) | FR2435442A1 (de) |
GB (1) | GB2031395B (de) |
HU (1) | HU180034B (de) |
IT (1) | IT1198313B (de) |
PL (1) | PL117242B1 (de) |
PT (1) | PT70125A (de) |
RO (1) | RO78238A (de) |
YU (1) | YU41174B (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL68311A0 (en) * | 1982-04-29 | 1983-07-31 | Scras | Modified clays,their preparation and pharmaceutical compositions containing them |
GB8421603D0 (en) * | 1984-08-24 | 1984-09-26 | British Petroleum Co Plc | Synthetic smectites and stabilised pillared analogues |
US4745092A (en) * | 1987-04-27 | 1988-05-17 | The Dow Chemical Company | Strengthened cordierite having minor amounts of calcia |
FR2639148B1 (fr) * | 1988-11-16 | 1991-08-02 | Merlin Gerin | Declencheur magnetique a large plage de reglage du seuil de declenchement |
GB9720061D0 (en) | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
US6358365B1 (en) * | 1999-12-14 | 2002-03-19 | Hercules Incorporated | Metal silicates, cellulose products, and processes thereof |
US20070154603A1 (en) * | 2005-12-30 | 2007-07-05 | Withiam Michael C | Treatment of cooking oils and fats with sodium magnesium aluminosilicate materials |
MY157620A (en) | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
GB0714670D0 (en) | 2007-07-27 | 2007-09-05 | Ineos Healthcare Ltd | Use |
GB0720220D0 (en) | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
GB0913525D0 (en) | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
GB201001779D0 (en) | 2010-02-04 | 2010-03-24 | Ineos Healthcare Ltd | Composition |
US8865123B1 (en) | 2010-09-16 | 2014-10-21 | Mo-Sci Corporation | Strontium phosphate microparticle for radiological imaging and therapy |
US9849200B2 (en) | 2010-09-16 | 2017-12-26 | Mo-Sci Corporation | Strontium phosphate microparticle for radiological imaging and therapy |
US9119887B2 (en) | 2010-09-16 | 2015-09-01 | Mo-Sci Corporation | Low-density magnesium-aluminum-silicate (MAS) microparticles for radiotherapy and/or radioimaging |
EP3746513A4 (de) * | 2018-02-02 | 2021-11-10 | W. R. Grace & Co.-Conn | Antazida für polymere |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2384563A (en) * | 1940-03-21 | 1945-09-11 | Charles H Burton | Magnesium silicates and process for making same |
US2970889A (en) * | 1956-09-26 | 1961-02-07 | Fuji Chem Ind Co Ltd | Process for the manufacture of magnesium aluminosilicate for medical uses |
US2990247A (en) * | 1958-01-27 | 1961-06-27 | Mallinckrodt Chemical Works | Aluminum compounds |
FR1330121A (fr) * | 1959-07-22 | 1963-06-21 | Mallinckrodt Chemical Works | Perfectionnements apportés aux procédés de préparation de silicates doubles d'aluminium et de magnésium |
FR53M (fr) * | 1960-07-11 | 1961-01-09 | Laboratoire A Castaigne | Applications thérapeutiques de l'arginase corps (45-25c) |
GB925001A (en) * | 1960-09-28 | 1963-05-01 | Reckitt & Sons Ltd | Pharmaceutical compositions |
US3032394A (en) * | 1960-12-06 | 1962-05-01 | Fuji Chem Ind Co Ltd | Process for manufacture of magnesium alumino-silicate |
DE1667490B1 (de) * | 1967-02-10 | 1971-07-01 | Fuji Chem Ind Co Ltd | Verfahren zur herstellung von magnesium aluminiumsilicat fuer medizinische zwecke |
FR1519706A (fr) * | 1967-02-16 | 1968-04-05 | Fuji Chem Ind Co Ltd | Procédé de préparation d'aluminosilicate de magnésium |
FR6778M (de) * | 1967-07-10 | 1969-03-10 | ||
US3636200A (en) * | 1969-06-09 | 1972-01-18 | Hoffmann La Roche | Pharmaceutical suspension |
US3767794A (en) * | 1969-11-21 | 1973-10-23 | Richardson Merrell Inc | Antifoam preparations and method of preparing same |
JPS5510539B2 (de) * | 1972-05-22 | 1980-03-17 | ||
US4108984A (en) * | 1977-01-14 | 1978-08-22 | Masataro Sato | Compositions and methods for the treatment of athlete's foot |
PL59294Y1 (en) * | 1997-06-30 | 2002-08-30 | Jerzy Boltromiuk | Central heating boiler |
-
1979
- 1979-07-30 FR FR7919521A patent/FR2435442A1/fr active Granted
- 1979-08-13 IT IT25088/79A patent/IT1198313B/it active
- 1979-08-21 YU YU2047/79A patent/YU41174B/xx unknown
- 1979-08-24 US US06/069,542 patent/US4339421A/en not_active Expired - Lifetime
- 1979-08-27 PT PT70125A patent/PT70125A/pt unknown
- 1979-09-04 ES ES484103A patent/ES484103A1/es not_active Expired
- 1979-09-05 RO RO7998603A patent/RO78238A/ro unknown
- 1979-09-05 PL PL1979218133A patent/PL117242B1/pl unknown
- 1979-09-06 DD DD79215388A patent/DD145740A5/de not_active IP Right Cessation
- 1979-09-06 GB GB7930962A patent/GB2031395B/en not_active Expired
- 1979-09-06 DE DE2936078A patent/DE2936078C2/de not_active Expired
- 1979-09-07 HU HU79OA627A patent/HU180034B/hu not_active IP Right Cessation
- 1979-09-07 AR AR277990A patent/AR221103A1/es active
Also Published As
Publication number | Publication date |
---|---|
IT1198313B (it) | 1988-12-21 |
FR2435442A1 (fr) | 1980-04-04 |
GB2031395B (en) | 1982-10-13 |
US4339421A (en) | 1982-07-13 |
HU180034B (en) | 1983-01-28 |
GB2031395A (en) | 1980-04-23 |
AR221103A1 (es) | 1980-12-30 |
DD145740A5 (de) | 1981-01-07 |
YU204779A (en) | 1984-02-29 |
DE2936078A1 (de) | 1980-03-20 |
RO78238A (ro) | 1982-04-12 |
DE2936078C2 (de) | 1982-03-11 |
IT7925088A0 (it) | 1979-08-13 |
YU41174B (en) | 1986-12-31 |
PT70125A (fr) | 1979-09-01 |
PL218133A1 (de) | 1980-06-02 |
ES484103A1 (es) | 1980-04-16 |
FR2435442B1 (de) | 1983-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL117242B1 (en) | Method for manufacturing synthetic aluminium and magnesium silicatejuminija | |
DE2905256C2 (de) | Basisches Aluminium-magnesium-carbonat | |
KR19980703280A (ko) | 선택된 탄산란탄 수화물을 함유하는 약학적 조성물 | |
WO2008087135A1 (de) | Eisen-kohlenhydrat-komplex-verbindungen | |
US4537771A (en) | Antacids containing zeolitic molecular sieves | |
EP0040521B1 (de) | Antacidum auf der Basis von Magnesium-Aluminium-Hydroxyd und seine Herstellung | |
US4804536A (en) | Dietary fibres of seaweed having ion-exchange ability | |
FI79945C (fi) | Foerfarande foer framstaellning av nya modifierade leror. | |
CS223968B2 (en) | Method of making the synthetic hydrated magnesium aluminosilicate | |
US3491135A (en) | Pamoates of (3-cyclohexyl-3-hydroxy-3-phenylpropyl) triethylammonium having unobjectionable flavors | |
DE69008058T2 (de) | Salze von Acrylsäure, Verfahren zu ihrer Herstellung, pharmazeutische Zusammensetzungen, die sie enthalten und deren Verwendung in der Medizin. | |
DD147544A5 (de) | Verfahren zur herstellung von rutin-poly(h)-sulfaten | |
GB2119355A (en) | Modified clays | |
DE1767994C2 (de) | Arzneimittel mit antacidem und absorptivem Wirkstoff | |
AU2002312652B2 (en) | Laxative preparation | |
JPS6348808B2 (de) | ||
CA1252045A (en) | Fluidized magaldrate suspension | |
US4215136A (en) | Insoluble metal salts of N-acetyl-tryptophane and use thereof | |
SI7912047A8 (sl) | Postopek za pridobivanje sintetičnega magnezijevega aluminijevega silikata | |
KR20100094991A (ko) | 궤양 치료제 | |
JPH0225414A (ja) | 持続性経口剤 | |
CS207459B2 (en) | Method of making the neutralization antiacidic means | |
DE1807733A1 (de) | Basisches Wismutinosithexaphosphat | |
CN105055443A (zh) | 羟基铝蒙脱石在制备抗酸剂中的应用 |